Cite
MLA Citation
Christine I. Chen et al.. “A phase 2 study of ofatumumab (Arzerra®) in combination with a pan-AKT inhibitor (afuresertib) in previously treated patients with chronic lymphocytic leukemia (CLL)*.” Leukemia & lymphoma, vol. 60, no. 1, 2019, pp. 92–100. http://access.bl.uk/ark:/81055/vdc_100077465215.0x000029